AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06179134 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Goal Management Training
Description: The main objective of GMT intervention are to train individuals to periodically STOP what they are doing, attend to task goals, evaluate their performance and monitor or check outcomes as they proceed (Levine \& Stamenova, 2017).
Study NCT06794125 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Hypofractionated Radiation Therapy
Description: Hypofractionated, dose-escalated, esophageal-sparing intensity modulated radiation therapy
Study NCT05377983 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lavender oil inhalation will be performed by placing two drops of 2% lavender oil on a 5x5 cm sterile gauze cloth and asking the patient to smell it for three to five minutes
Description: During the hospitalization period after CABG surgery, 2% lavender oil (Lavandula angustifolia) inhalation will be applied to the intervention group three times a day.
Study NCT05755048 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Investigational drug: Recombinant Anti-HER2 Humanized Monoclonal Antibody - Monomethyl Auristatin F Conjugates for Injection (FS-1502)
Description: Experimental: FS-1502 Dosage form: lyophilized powder Specification: 30 mg/vial Dose: 2.3 mg/kg, once every 3 weeks, 21 days as a cycle; Method of administration: intravenous drip.
Study NCT05755048 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Control drug: Trastuzumab emtansine (Kadcyla, T-DM1)
Description: Active Comparator: Trastuzumab Emtansine (T-DM1) Trade name: Kadcyla Dosage form: lyophilized powder Specification: 100 mg/vial Dose: 3.6 mg/kg, once every 3 weeks, 21 days as a cycle; Method of administration: intravenous drip (this drug has been approved for marketing. Please refer to the package insert for details).
Study NCT05631197 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Biorepair Total Protection Plus + desensitizing enamel-repair shock treatment
Description: Domiciliary use twice a day
Study NCT05631197 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sensodyne Repair & Protect
Description: Domiciliary use twice a day
Study NCT06794125 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Radiation Therapy
Description: standard of care palliative thoracic radiotherapy using volumetric modulated arc therapy/intensity-modulating radiotherapy
Study NCT06797765 — intervention group
Intervention type: DEVICE
Intervention: OCTA
Description: Optical Coherence Tomography Angiography
Study NCT06793657 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: computed tomography and poppy seed
Description: comparison of both interventions
Study NCT05150873 — intervention group
Intervention type: OTHER
Intervention: CTA evaluation
Description: Any pre-operattive CTA of the patients of the cohort will be carefully evaluated to determine the theoric anatomical feasibility of an off the shelf Endograft, particularly in patients with an angulated and short aortic neck
Study NCT06796530 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cardiopulmonary exercise test (CPET)
Description: Participants undergo a CPET on a stationary bike, measuring gas exchange, ECG, and other parameters. The protocol includes 3 minutes of cycling at a constant load (body weight/2 in Watts), followed by a maximal effort test with an incremental load (Ramp protocol body weight (kg) / 4 in Watts per minute).
Study NCT06796530 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: High-intensity circuit training
Description: The patients will undergo a 10-minute warm-up, followed by \~30 high intensity exercise circuit.
Study NCT06794957 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AL8326 tablets
Description: 10mg/tablet;Oral administration, once daily.
Study NCT06796868 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GW117 Tablets
Description: GW117 Tablets 20mg orally once a day
Study NCT06796868 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GW117 Tablets
Description: GW117 Tablets 20mg\*2 orally once a day
Study NCT06796868 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GW117 Tablets
Description: GW117 Tablets 20mg\*3 orally once a day
Study NCT06796868 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo orally once a day
Study NCT06796569 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: systemic immune inflammatory index
Description: Systemic immune inflammatory index (SII) is a combination of three hematological parameters (platelets, neutrophils, and lymphocytes) and it is calculated using the following formula: SII = (neutrophil count × platelet count)/lymphocyte count.
Study NCT06788704 — intervention group
Intervention type: DRUG
Intervention: Tadalafil 5mg
Description: Patient recive tadalafil 5mg once daily early post turp
Study NCT06788704 — intervention group
Intervention type: DRUG
Intervention: Placebo
Description: Patient recive placebo once daily early post turp
Study NCT06793904 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aromatase inhibitor Letrozole
Description: 2.5 mg tab twice daily from the 3rd day of the cycle for 5 days
Study NCT04929899 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Bright Ideas - CIN Training
Description: Bright IDEAS is a validated problem-solving skill training intervention.
Study NCT06796972 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Semi-structured interviews with a psychologist
Description: Semi-directed interviews using an interview guide on different themes
Study NCT06791382 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: AI-Based Diagnostic and Prognostic Model
Description: This intervention involves an AI system that integrates multimodal data, including patient medical history, laboratory test results, clinical observations, and treatment data, to predict the risk of hospital-acquired infections (HAIs). The system uses deep learning algorithms to provide real-time, accurate predictions, enabling early identification of patients at risk for infections. By analyzing historical health data, the model aims to predict potential infection developments, improving early detection, prevention strategies, and patient outcomes in hospital settings.
Study NCT04520217 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 4% Imipramine Cream
Description: 4% Imipramine Cream
Study NCT04520217 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Base Cream
Description: Base Cream
Study NCT06793618 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Z-track technique
Description: In this method, the neonates are in supine position, the skin is moved and held from the injection site 2 to 3 cm to the side or downward using the non- dominant hand, to ensure that blood vessel wasn't penetrated aspiration on the syringe must perceive the injection and then the medication is to be injected slowly. Researcher assistant that is unaware of the injection method performs the recording of the pain intensity and leakage diameter on the observation form.
Study NCT06066021 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: health educational sessions in diabetic patients type 2.
Description: Professionals from different areas will be invited to carry out the sessions at Visit 2, namely on: mental health, physical activity, nutrition and self-care.
Study NCT05295121 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XC221 100 mg tablets
Description: XC221, 3 discrete doses separated by 7-day wash-out periods
Study NCT05997914 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Storytelling Intervention
Description: Participants assigned to the intervention group will watch videos presenting stories of African American patients about their experiences with using anticoagulation or blood thinners throughout a 90-day period.
Study NCT06068478 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Qingzhu Granules
Description: During the 72-hour treatment period, participants will receive 9 sacks of Qingzhu granules.Oral administration, 1 sack (6g) per time, 3 times daily.
Study NCT06068478 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Qingzhu Granules Placebo
Description: During the 72-hour treatment period, participants will receive 9 sacks of Qingzhu granules Placebo.Oral administration, 1 sack (6g) per time, 3 times daily.
Study NCT05301257 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention group SOSteniamoci
Description: Intervention based on cognitive behavioural therapy principles and culturally adapted to Italian population. Intervention's main purpose is to reduce caregiver burden and increase quality of life. Intervention contains psycho-educational elements as well as examples and exercises.
Study NCT05866029 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Denosumab
Description: Active Comparator: 60mg of Denosumab treatment by subcutaneous injection
Study NCT05866029 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Denosumab
Description: Active Comparator: 60mg of Denosumab treatment by subcutaneous injection
Study NCT05866029 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Teriparatide
Description: Teriparatide was sequentially treated with Denosumab
Study NCT05647772 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: UseIt! App
Description: The UseIt! app is a parenting app with evidence-based parent management content. The app runs on both Android and iOS devices. It includes a digital library of parent management skills, a trouble-shooting guide, a behavior diary, a point counter, and a skills-alarm.
Study NCT05647772 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Coach
Description: The coach is be a bachelor's level paraprofessional with a degree in psychology or an allied discipline (e.g., social work) who provides support to parents. The coach will provide motivation and accountability but will not provide therapeutic/clinical support. The primary goal of the coach is to increase participant engagement with the UseIt! mHealth system.
Study NCT05647772 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: SmilingMind App
Description: The control app is a mindfulness app called SmilingMind. It is available for both Android and iOS devices.
Study NCT05772455 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XZB-0004
Description: Part 1a: 100mg BID, 150mg BID, and 200mg BID of XZB-0004 are planned to be evaluated, and the possibility of exploring higher or lower doses is not ruled out. Continuous administration of XZB-0004 for 21 days is a treatment cycle. Part 1b: XZB-0004 in combination with Penpulimab in subjects with advanced NSCLC or solid tumors, starting at a dose level down from the RP2D of XZB-0004 monotherapy- cohort 1: Advanced or metastatic NSCLC with advanced disease progression after treatment with PD-1 or PD-L1 inhibitors; cohort 2: Advanced or metastatic NSCLC with advanced disease progression after platinum-containing chemotherapy without prior use of any immunocheckpoint inhibitors; cohort3: Advanced or metastatic solid tumors that cannot be radically cured by surgery or local therapy, including but not limited to urothelial carcinoma, melanoma, etc. Subjects had disease progression since last antitumor therapy, no availability or intolerance or refusal of standard therapy.
Study NCT05083403 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AcumenTM HPI Software Feature
Description: The AcumenTM HPI Feature Software provides the clinician with physiological insight into a patient's likelihood of trending toward a hypotensive event. The AcumenTM HPI Feature Software suite is enabled by the minimally invasive Acumen IQ sensor.
Study NCT05083403 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Non-protocolized Standard of Care
Description: Non-protocolized standard of care to treat subjects
Study NCT06794723 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 5-strain probiotic plus prebiotic natural health product
Description: The investigational product is a 5-strain probiotic plus prebiotic natural health product for patients with Type 2 diabetes. Other ingredients include oligofructose, grape food color, magnesium stearate, silica and a delayed release capsule.~Recommended storage is in a refrigerated environment at approximately 4°C. The product should not be frozen. It is recommended that the product be used within 2 months after opening the bottle. Participants are asked to take 2 capsules daily with food, 1 in the morning and 1 in the evening. There is ≥ 2 billion AFU per dose in total.
Study NCT06794723 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Ingredients include oligofructose, grape food color, magnesium stearate, silica and a delayed release capsule.~Recommended storage is in a refrigerated environment at approximately 4°C. The product should not be frozen. It is recommended that the product be used within 2 months after opening the bottle. Participants are asked to take 2 capsules daily with food, 1 in the morning and 1 in the evening.
Study NCT06797219 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low Level Laser Therapy for Intraventricular Hemorrhage of Prematurity
Description: The experimental arm will be administered treated with the study device. It will be 10 mW/cm\^2 of 650nm laser through use of a novel laser device given for 5 minutes twice daily for 12 days.
Study NCT06793813 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cadonilimab，bevacizumab，docetaxel
Description: Patients receive Cadonilimab IV over 90 minutes on day 1. Patients also receive bevacizumab 7.5mg/kg IV on day 1 and docetaxel 60-75 mg/m2 IV over 60 minutes on day 1. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity.
Study NCT06794918 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: progressive relaxation exercise
Description: Researchers will teach individuals pge exercises to help them relax
Study NCT05910372 — intervention group
Intervention type: OTHER
Intervention: Color Comparison Task
Description: Participants are presented with a series of colored squares and are instructed to compare the colors of two sequentially presented stimuli.
Study NCT05910372 — intervention group
Intervention type: OTHER
Intervention: N-back Task
Description: Participants are presented with a sequence of letters and they must indicate whether the current stimulus matches the one presented 2 steps back in the sequence.
Study NCT05699499 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: KeryFlex
Description: KeryFlex is a painless, in-office cosmetic application of artificial nails which improves the appearance of nails damaged by various nail disorders. The composite resin creates a flexible, nonporous nail that allows the remaining natural nail to grow. KeryFlex is a three-step procedure that takes 10 to 15 minutes for a typical nail. At least 15% of the existing nail must be present for the resin application. The material used in KeryFlex is approved as a cosmetic by the FDA.
Study NCT04647578 — intervention group
Intervention type: DEVICE
Intervention: GT3X Actigraph accelerometer.
Description: GT3X Actigraph accelerometer during 7 days
Study NCT06382584 — intervention group
Intervention type: PROCEDURE
Intervention: Femoral fracture surgery
Description: Hip fracture surgery
Study NCT02503553 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Option grid for cerebral aneurysm treatment
Description: Patients will receive an option grid during the preoperative visit. They will be given the chance to read it and ask questions. The option grid will include head to head comparative answers for the two interventions available for cerebral aneurysms (surgical clipping and endovascular coiling). The interaction with the aneurysm surgeon will be voice recorded.
Study NCT02503553 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Patients will receive the standard information booklet for cerebral aneurysms during the preoperative visit. They will be given the chance to ask questions. The interaction with the aneurysm surgeon will be voice recorded.
Study NCT05118165 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dietary supplement with protein
Description: Will be included protein supplements in the preoperative diet.
Study NCT06795919 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: : delayed surgical repair of alveolar cleft using particulate cortico-cancellous anterior iliac bon
Description: skin incision was marked 2-4 cm from the crest to anterior iliac spine height. This is done to avoid pain at the beltline if the incision is made directly over the anterior ilium. As well as avoid injury to the lateral femoral cutaneous nerve. After the anatomical marking are drawn using betadine solution, the site is injected with local anesthesia at the subcutaneous level. The skin incision line is made parallel to the iliac crest and posterior to the anterior iliac spine. Scalpel blade number 10 is used. The incision of the skin and subcutaneous fat was performed. Blunt dissection is carried out at the level of subcutaneous tissues to separate the fascia from fat. Cautery is used to control any hemorrhage. Using a number 15 blade, fascia was incised which covers the iliac spine. A hypo vascular plane was identified. It is located over the anterior iliac spine, as well as between the insertions of tensor fascia laterally and the external and the transverse abdominal muscles medially
Study NCT05484934 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Regenerative post mastectomy surgery
Description: Implantation of the Nipple-Areolar Complex (NAC) Reconstruction Using a Decellularized Donor NAC Graft (DCLNAC)
Study NCT04588415 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bereavement Virtual Support Group
Description: Family members who experience loss will be invited to attend a virtual support group (VSG) led by Bereaved Families of Ontario- Ottawa (BFO). In pre-COVID-19 times, BFO presented monthly Support and Share nights with guest speakers, followed by breakout peer support groups for all different types of losses: loss of child, spouse, parent, loss by suicide, etc. These groups are facilitated by trained volunteers with a shared loss and include between 75 and 150 participants. These Support and Share Nights serve as intake sessions- interested participants from the breakout groups can attend Closed Groups where a smaller group of participants (up to 12) explore their grief more deeply. These run over 8-10 consecutive weeks with the same group of participants. They are led by trained facilitators who have experienced similar losses. Each week has a different theme, based on evidence-based components of bereavement support (e.g. writing a letter to the deceased).
Study NCT04973683 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AL101
Description: Given IV
Study NCT04973683 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Therapeutic Conventional Surgery
Description: Undergo standard of care surgery
Study NCT06656117 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Elliptical training
Description: • Throughout the training, participants' heart rates were monitored, and they were asked to report any discomfort or unusual signs.
Study NCT06656117 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resistance training
Description: • Throughout the training, participants' heart rates were monitored, and they were asked to report any discomfort or unusual signs.
Study NCT06653751 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Reminder App
Description: he purpose of the app is to remind patients irradiated for prostate cancer in an intuitive, unobtrusive and supportive way to drink 300 ml of water 45 minutes prior to each radiation session.
Study NCT06656650 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Commensality groups
Description: Participants will attend at least 3 out of 6 commensality groups over the course of 6 months.
Study NCT06661330 — intervention group
Intervention type: OTHER
Intervention: Behavioral Treatment
Description: Participants followed a 6-month hypocaloric Mediterranean-style diet, reducing energy intake by approximately 600 kcal/day. The diet emphasized fruits, vegetables, whole grains, and fish, while limiting red meat and processed foods. Additionally, participants were required to perform moderate physical activity, including 50 minutes of aerobic exercise, 3 times a wee
Study NCT06792513 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Clear Aligner
Description: In this intervention, clear aligners were digitally designed using three-dimensional models for the upper jaw. Attachments were applied to the patients, specifically placed on the incisors exhibiting a crossbite relationship and on the permanent first molars in the posterior region. The series of clear aligners were replaced every 10 days. The aligners were used full-time, except during meals and tooth brushing.
Study NCT06792513 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Labiolingual Spring Hawley Appliance
Description: In this intervention, a custom-made labiolingual spring Hawley appliance was designed for the upper jaw. It included two Adams clasps, a vestibular arch, and an active labiolingual spring positioned on the palatal side of the incisor in crossbite. The spring was activated every 10 days. The appliance was used full-time, except during meals and tooth brushing.
Study NCT06784284 — intervention group
Intervention type: OTHER
Intervention: Glasgow Outcome Scale -Extended (GOSE)
Description: Questionnaire to cotate the neurological deterioration following mild head trauma. Score from 1 to 8, the higher the number the better the outcome